Blog
/
Sales Performance

Solution selling: latent pain is the part teams drop

Solution selling was built to create demand where none was expressed, and most implementations drop exactly that part. Where the method actually came from, what latent pain means in practice, and the structural limit it hits with modern buying committees.

On this page
IntroductionWhat changed in 2026Frameworks comparedMEDDIC deep diveAutomating data captureMeasuring impactConclusion
Share

Solution selling is a methodology in which the seller diagnoses and develops a buyer's business problem before presenting anything, so the product arrives as the answer to a problem the buyer now fully understands. Its central and most-ignored claim is that the best opportunities are not the buyers already shopping, but the ones who have a problem they have stopped noticing. This article covers where the method actually came from, the distinction between latent and active pain that most implementations quietly drop, and the structural limit that makes solution selling insufficient on its own in 2026.

If a buyer is already evaluating vendors, who created the demand you are now competing for?

The bottom line: solution selling degrades into a synonym for asking good questions, and in doing so loses its actual thesis. The method was built to create demand where none was expressed, by developing a problem the buyer had accepted as normal into one with a cost attached. Teams that only sell to buyers who already know they have a problem compete for the same accounts as everyone else, and compete on price.

Where it came from, and who usually gets the credit

Almost every article on this subject credits Mike Bosworth. The record is slightly different. As Arpedio documents, the term traces to Frank Watts, who developed the approach at Wang Laboratories in 1975 in response to a specific problem: computer products were complex, buyers were not technical, and feature-led pitches failed because buyers could not connect features to outcomes. Watts reversed the sequence, starting from the outcome and working back to the product. Bosworth picked it up at Xerox in the late 1970s and turned it into something teachable, then set it out in his book Solution Selling: Creating Buyers in Difficult Selling Markets, later extended by Keith Eades in The New Solution Selling.

The detail matters beyond trivia, because the intellectual property changed hands several times and now sits with Richardson, which is why the phrase drifted into a generic label. Unlike Sandler, no single owner has kept developing it, so what most teams call solution selling today is a loose consultative posture rather than the original discipline.

Latent pain, and why almost nobody sells to it

The method distinguishes three levels of buyer need, and the sequence is the whole point. Latent pain is a problem the buyer has and has normalised: no budget, no project, no urgency. Admitted pain is a problem they acknowledge. Active pain is one they are already spending money to solve.

Most sellers work exclusively at the third level, because those buyers answer emails. The consequence is arithmetic: everyone competes for the same small pool of in-market accounts, differentiation collapses onto price, and the vendor who created the buyer's understanding of the problem in the first place is usually the one holding the criteria. Selling to latent pain is harder, slower, and it is where the method's actual advantage lives.

The two classic tools

ToolWhat it doesUsual failure
Pain chainMaps how one person's problem creates another's, up to the executive levelStops at the first person interviewed
Vision creationHelps the buyer picture the solved state before any product appearsBecomes a disguised demo

The pain chain is the more valuable of the two and the more often truncated. As Umbrex describes it, the tool maps the chain of problems inside an organisation, showing how individual pain points interconnect and how solving one affects other areas. A chain built from a single conversation is not a chain, it is a complaint.

Vision creation fails differently. Done properly the buyer describes the solved state in their own words and the seller stays quiet; done badly the seller narrates their product with the pronouns changed, which the buyer detects immediately.

Where the method breaks in 2026

  • It was designed around one seller and one buyer, while enterprise deals now involve six to ten stakeholders or more.
  • A pain chain assembled by hand assumes the seller can interview several people, which access rarely permits early.
  • Buyers arrive with more information, so a vision built without new insight adds nothing they had not already assembled.
  • The diagnosis lives in one rep's head, so it does not survive a handover or a manager's review.

The first point is the structural one, and Arpedio names it plainly: the methodology was built for a seller-buyer dyad, and a committee with internal conflict is a different object. The practical answer is not to abandon the method but to pair it with a stakeholder layer, which is what Miller Heiman supplies.

How it relates to the methods that followed

Solution selling is the ancestor of most modern problem-centric approaches, and knowing the lineage tells you which one to use. Gap selling takes the same premise and adds the demand that everything be quantified, including the root cause. Consultative selling generalised the posture and, in doing so, made it universal enough to stop differentiating anyone. Our comparison of 12 sales frameworks positions them side by side.

Put simply: solution selling tells you to develop the pain, gap selling tells you to measure it, Miller Heiman tells you whose pain matters.

Finding latent pain at more than one account at a time

The practical obstacle to selling into latent pain has always been that you have to know it exists before the buyer says so. That knowledge does exist inside most companies, scattered across conversations where someone described a workaround, a manual process or a frustration they had stopped questioning, and then nobody recorded it. Praiz turns those moments into structured data: specialized agents extract the problems, workarounds and frustrations buyers actually voice, and aggregate them across the whole account base. What emerges is the pattern no single call reveals, namely which normalised problems recur across a segment, which is exactly the raw material for developing latent pain at the next account. Praiz customer teams multiply weak-signal detection by 10 this way. Extraction is configured to your market in the Praiz AI agents library, with onboarding handled alongside you rather than left as a template.

See it in action

The problems your market has stopped noticing

Praiz extracts the workarounds and frustrations buyers mention in passing, and shows which ones recur across your segment.

Book a demo →

Frequently asked questions

What is the difference between latent and active pain?

Latent pain is a problem the buyer has but has accepted as normal, with no budget and no project attached. Active pain is one they are already trying to solve.

Selling only to active pain means competing for the same in-market accounts as everyone else.

Who invented solution selling?

Frank Watts developed the approach at Wang Laboratories in 1975.

Mike Bosworth picked it up at Xerox in the late 1970s and turned it into a structured, teachable methodology, which is why he is usually credited alone.

Is solution selling outdated?

The core discipline holds, but the method was designed around one seller and one buyer.

Enterprise deals now involve six to ten stakeholders or more, so it needs a stakeholder mapping layer on top to survive a modern buying committee.

There’s a gold mine hidden in your conversations.